Here you will find the most recent news/events from our law firm as well as analyses and articles on the latest legal issues.
Webinar
24.09.2024
24/09
12:30 PM
WebinarWebinar
01.10.2024
01/10
12:30 PM
WebinarWebinar
05.11.2024
05/11
12:30 PM
WebinarWebinar
12.11.2024
12/11
12:30 PM
WebinarWebinar
26.11.2024
26/11
12:30 PM
WebinarWebinar
10.12.2024
10/12
12:30 PM
WebinarWebinar
AI & Law webinar series: Latest developments and trends (German-language event)
Subsidies and State Aid
Competition/Antitrust
Mergers and Acquisitions
Hot
Topic
Field-testing the new EU Foreign Subsidies Regulation
Firm News
‘Best Lawyers’ in Germany: Gleiss Lutz takes Law Firm of the Year for Competition/Antitrust and Public Law, five Lawyer of the Year awards and 344 recommendations
Event
16.06.2023
16/06
12:30 PM
BerlinBerlin
Healthcare Forum (German-language event)
Webinar
27.10.2022
27/10
01:00 PM
WebinarWebinar
10.11.2022
10/11
01:00 PM
WebinarWebinar
Third-country access, competition register and supply chain management: New developments in public procurement law (German-language event)
Mandate
Gleiss Lutz advises district of Calw on takeover of Sana-Kliniken Bad Wildbad and subsequent merger into Kreiskliniken Calw
Commercial
Public Law
Public Procurement
Federal Armed Forces Procurement Acceleration Act
Mandate
Gleiss Lutz advises PHOENIX on the acquisition of McKesson’s European business
Webinar
21.06.2021
21/06
01:30 PM
WebinarWebinar
Pharmaceuticals and VAT in Statutory Health Insurance (German-language event)
Mandate
Gleiss Lutz advises Zur Rose Group on the establishment of the Doc Morris Adipositas Care portal
Public Law
Public Procurement
Public procurement arrangements under the Trade and Cooperation Agreement between the UK and the EU since 1 January 2021
Mandate
Gleiss Lutz advises American Industrial Partners on its acquisition of the Personal Care business from Domtar Corp.
Firm News
2020 JUVE Awards: Gleiss Lutz named Law Firm of the Year for corporate and healthcare
Webinar
20.10.2020
20/10
01:30 PM
WebinarWebinar
Investments in the healthcare sector in 2020/2021:
Risk, opportunity or both? (German-language event)
Mandate
Hot
Topic
Gleiss Lutz advises founder and shareholder Dr. Ingmar Hoerr in connection with CureVac’s IPO on the New York stock exchange Nasdaq
Mandates & Firm News
Click here for Information on our mandates and firm news